Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis. Lugaresi A, di Ioia M, Travaglini D, Pietrolongo E, Pucci E, Onofrj M Neuropsychiatr Dis Treat. 2013; 9:893-914. Epub 2013 Jun 24. PMID: 23836975. Abstract CommentRecommendBookmarkWatch